Sex differences in the reinstatement of methamphetamine seeking after forced abstinence in Sprague-Dawley rats

Frontiers in Psychiatry

Volumn 6, Issue JUL, 2015, Pages

  Ruda Kucerova, Jana ^a   Amchova, Petra ^a   Babinska, Zuzana ^a   Dusek, Ladislav ^a   Micale, Vincenzo ^a,b   Sulcova, Alexandra ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Forced abstinence; Methamphetamine; Reinstatement of drug seeking behavior; Sex gender differences; Sprague Dawley rats

Indexed keywords

METHAMPHETAMINE;

ABSTINENCE; ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; ESTRUS CYCLE; FEMALE; INFUSION PUMP; INSTRUMENTAL CONDITIONING; LOCOMOTION; MALE; NONHUMAN; RAT; REINFORCEMENT; SEX DIFFERENCE; SPRAGUE DAWLEY RAT;

EID: 84940100445     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2015.00091     Document Type: Article

References (54)

1. Becker JB, Hu M. Sex differences in drug abuse. Front Neuroendocrinol (2008) 29:36-47. doi:10.1016/j.yfrne.2007.07.003.
2. Dluzen DE, Liu B. Gender differences in methamphetamine use and responses: a review. Gend Med (2008) 5:24-35. doi:10.1016/S1550-8579(08)80005-8.
3. Bobzean SA, Denobrega AK, Perrotti LI. Sex differences in the neurobiology of drug addiction. Exp Neurol (2014) 259:64-74. doi:10.1016/j.expneurol.2014.01.022.
4. Fattore L, Melis M, Fadda P, Fratta W. Sex differences in addictive disorders. Front Neuroendocrinol (2014) 35:272-84. doi:10.1016/j.yfrne.2014.04.003.
5. Brecht ML, O'Brien A, Von Mayrhauser C, Anglin MD. Methamphetamine use behaviors and gender differences. Addict Behav (2004) 29:89-106. doi:10.1016/S0306-4603(03)00082-0.
6. Munro CA, Mccaul ME, Wong DF, Oswald LM, Zhou Y, Brasic J, et al. Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry (2006) 59:966-74. doi:10.1016/j.biopsych.2006.01.008.
7. Terner J, de Wit H. Menstrual cycle phase and responses to drugs of abuse in humans. Drug Alcohol Depend (2006) 84:1-13. doi:10.1016/j.drugalcdep.2005.12.007.
8. Brecht ML, Herbeck D. Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors. Drug Alcohol Depend (2014) 139:18-25. doi:10.1016/j.drugalcdep.2014.02.702.
9. Reichel CM, Chan CH, Ghee SM, See RE. Sex differences in escalation of methamphetamine self-administration: cognitive and motivational consequences in rats. Psychopharmacology (Berl) (2012) 223:371-80. doi:10.1007/s00213-012-2727-8.
10. Cox BM, Young AB, See RE, Reichel CM. Sex differences in methamphetamine seeking in rats: impact of oxytocin. Psychoneuroendocrinology (2013) 38:2343-53. doi:10.1016/j.psyneuen.2013.05.005.
11. Lynch WJ, Carroll ME. Reinstatement of cocaine self-administration in rats: sex differences. Psychopharmacology (Berl) (2000) 148:196-200. doi:10.1007/s002130050042.
12. Lynch WJ, Taylor JR. Sex differences in the behavioral effects of 24-h/day access to cocaine under a discrete trial procedure. Neuropsychopharmacology (2004) 29:943-51. doi:10.1038/sj.npp.1300389.
13. Klein LC, Popke EJ, Grunberg NE. Sex differences in effects of predictable and unpredictable footshock on fentanyl self-administration in rats. Exp Clin Psychopharmacol (1997) 5:99-106. doi:10.1037/1064-1297.5.2.99.
14. Fuchs RA, Branham RK, See RE. Different neural substrates mediate cocaine seeking after abstinence versus extinction training: a critical role for the dorsolateral caudate-putamen. J Neurosci (2006) 26:3584-8. doi:10.1523/JNEUROSCI. 5146-05.2006.
15. Reichel CM, Bevins RA. Forced abstinence model of relapse to study pharmacological treatments of substance use disorder. Curr Drug Abuse Rev (2009) 2:184-94. doi:10.2174/1874473710902020184.
16. Yahyavi-Firouz-Abadi N, See RE. Anti-relapse medications: preclinical models for drug addiction treatment. Pharmacol Ther (2009) 124:235-47. doi:10.1016/j.pharmthera.2009.06.014.
17. Kucerova J, Vrskova D, Sulcova A. Impact of repeated methamphetamine pretreatment on intravenous self-administration of the drug in males and estrogenized or non- estrogenized ovariectomized female rats. Neuro Endocrinol Lett (2009) 30:663-70.
18. Castelli MP, Fadda P, Casu A, Spano MS, Casti A, Fratta W, et al. Male and female rats differ in brain cannabinoid CB1 receptor density and function and in behavioural traits predisposing to drug addiction: effect of ovarian hormones. Curr Pharm Des (2013) 20(13):2100-13. doi:10.2174/13816128113199990430.
19. Feltenstein MW, Henderson AR, See RE. Enhancement of cue-induced reinstatement of cocaine-seeking in rats by yohimbine: sex differences and the role of the estrous cycle. Psychopharmacology (Berl) (2011) 216:53-62. doi:10.1007/s00213-011-2187-6.
20. Chen HH, Yang YK, Yeh TL, Cherng CF, Hsu HC, Hsiao SY, et al. Methamphetamine-induced conditioned place preference is facilitated by estradiol pretreatment in female mice. Chin J Physiol (2003) 46:169-74.
21. Carroll ME, Anker JJ. Sex differences and ovarian hormones in animal models of drug dependence. Horm Behav (2010) 58:44-56. doi:10.1016/j.yhbeh.2009.10.001.
22. Anker JJ, Carroll ME. Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones. Curr Top Behav Neurosci (2011) 8:73-96. doi:10.1007/7854_2010_93.
23. Quinones-Jenab V, Jenab S. Progesterone attenuates cocaine-induced responses. Horm Behav (2010) 58:22-32. doi:10.1016/j.yhbeh.2009.10.002.
24. Lynch WJ, Sofuoglu M. Role of progesterone in nicotine addiction: evidence from initiation to relapse. Exp Clin Psychopharmacol (2010) 18:451-61. doi:10.1037/a0021265.
25. Schindler CW, Bross JG, Thorndike EB. Gender differences in the behavioral effects of methamphetamine. Eur J Pharmacol (2002) 442:231-5. doi:10.1016/S0014-2999(02)01550-9.
26. Mathews IZ, McCormick CM. Female and male rats in late adolescence differ from adults in amphetamine-induced locomotor activity, but not in conditioned place preference for amphetamine. Behav Pharmacol (2007) 18:641-50. doi:10.1097/FBP.0b013e3282effbf5.
27. Silverman JL, Koenig JI. Evidence for the involvement of ERbeta and RGS9-2 in 17-beta estradiol enhancement of amphetamine-induced place preference behavior. Horm Behav (2007) 52:146-55. doi:10.1016/j.yhbeh.2007.03.017.
28. Milesi-Halle A, Mcmillan DE, Laurenzana EM, Byrnes-Blake KA, Owens SM. Sex differences in (+)-amphetamine- and (+)-methamphetamine-induced behavioral response in male and female Sprague-Dawley rats. Pharmacol Biochem Behav (2007) 86:140-9. doi:10.1016/j.pbb.2006.12.018.
29. Milesi-Halle A, Hambuchen MD, Mcmillan DE, Michael Owens S. The pharmacokinetics of methamphetamine self-administration in male and female rats. Drug Alcohol Depend (2015) 150:164-9. doi:10.1016/j.drugalcdep.2015.02.032.
30. Emmett-Oglesby MW, Peltier RL, Depoortere RY, Pickering CL, Hooper ML, Gong YH, et al. Tolerance to self-administration of cocaine in rats: time course and dose-response determination using a multi-dose method. Drug Alcohol Depend (1993) 32:247-56. doi:10.1016/0376-8716(93)90089-9.
31. Vinklerova J, Novakova J, Sulcova A. Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. J Psychopharmacol (2002) 16:139-43. doi:10.1177/026988110201600204.
32. Kucerova J, Pistovcakova J, Vrskova D, Dusek L, Sulcova A. The effects of methamphetamine self-administration on behavioural sensitization in the olfactory bulbectomy rat model of depression. Int J Neuropsychopharmacol (2012) 15:1503-11. doi:10.1017/S1461145711001684.
33. Amchova P, Kucerova J, Giugliano V, Babinska Z, Zanda MT, Scherma M, et al. Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms. Front Pharmacol (2014) 5:44. doi:10.3389/fphar.2014.00044.
34. Kucerova J, Novakova J, Landa L, Sulcova A. Gender differences in cannabinoid and ecstasy interacting effects in mice. Homeost Health Dis (2006) 44:2.
35. Kucerova J, Sulcova A. Comparison of behavioural sensitization to ecstasy in mouse males and ovariectomized females with and without oestrogen substitution. Homeost Health Dis (2008) 50:2.
36. Robinson TE, Becker JB, Presty SK. Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences. Brain Res (1982) 253:231-41. doi:10.1016/0006-8993(82)90690-4.
37. Stohr T, Schulte Wermeling D, Weiner I, Feldon J. Rat strain differences in open-field behavior and the locomotor stimulating and rewarding effects of amphetamine. Pharmacol Biochem Behav (1998) 59:813-8. doi:10.1016/S0091-3057(97)00542-X.
38. Becker JB, Perry AN, Westenbroek C. Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis. Biol Sex Differ (2012) 3:14. doi:10.1186/2042-6410-3-14.
39. Grilly DM, Loveland A. What is a "low dose" of d-amphetamine for inducing behavioral effects in laboratory rats? Psychopharmacology (Berl) (2001) 153:155-69. doi:10.1007/s002130000580.
40. Milesi-Halle A, Hendrickson HP, Laurenzana EM, Gentry WB, Owens SM. Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats. Toxicol Appl Pharmacol (2005) 209:203-13. doi:10.1016/j.taap.2005.04.007.
41. Robinson TE. Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology (Berl) (1984) 84:466-75. doi:10.1007/BF00431451.
42. van Haaren F, Meyer ME. Sex differences in locomotor activity after acute and chronic cocaine administration. Pharmacol Biochem Behav (1991) 39:923-7. doi:10.1016/0091-3057(91)90054-6.
43. Harrod SB, Booze RM, Welch M, Browning CE, Mactutus CF. Acute and repeated intravenous cocaine-induced locomotor activity is altered as a function of sex and gonadectomy. Pharmacol Biochem Behav (2005) 82:170-81. doi:10.1016/j.pbb.2005.08.005.
44. Vansickel AR, Stoops WW, Rush CR. Human sex differences in d-amphetamine self-administration. Addiction (2010) 105:727-31. doi:10.1111/j.1360-0443.2009.02858.x.
45. Vansickel AR, Lile JA, Stoops WW, Rush CR. Similar discriminative-stimulus effects of D-amphetamine in women and men. Pharmacol Biochem Behav (2007) 87:289-96. doi:10.1016/j.pbb.2007.05.003.
46. Kennedy AP, Epstein DH, Phillips KA, Preston KL. Sex differences in cocaine/heroin users: drug-use triggers and craving in daily life. Drug Alcohol Depend (2013) 132:29-37. doi:10.1016/j.drugalcdep.2012.12.025.
47. Roth ME, Cosgrove KP, Carroll ME. Sex differences in the vulnerability to drug abuse: a review of preclinical studies. Neurosci Biobehav Rev (2004) 28:533-46. doi:10.1016/j.neubiorev.2004.08.001.
48. Roth ME, Carroll ME. Sex differences in the acquisition of IV methamphetamine self-administration and subsequent maintenance under a progressive ratio schedule in rats. Psychopharmacology (2004) 172:443-9. doi:10.1007/s00213-003-1670-0.
49. Justice AJ, De Wit H. Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol Biochem Behav (2000) 66:509-15. doi:10.1016/S0091-3057(00)00218-5.
50. Justice AJ, De Wit H. Acute effects of estradiol pretreatment on the response to d-amphetamine in women. Neuroendocrinology (2000) 71:51-9. doi:10.1159/000054520.
51. Becker JB, Molenda H, Hummer DL. Gender differences in the behavioral responses to cocaine and amphetamine. Implications for mechanisms mediating gender differences in drug abuse. Ann N Y Acad Sci (2001) 937:172-87. doi:10.1111/j.1749-6632.2001.tb03564.x.
52. White TL, Justice AJ, De Wit H. Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav (2002) 73:729-41. doi:10.1016/S0091-3057(02)00818-3.
53. Peck JA, Ranaldi R. Drug abstinence: exploring animal models and behavioral treatment strategies. Psychopharmacology (Berl) (2014) 231:2045-58. doi:10.1007/s00213-014-3517-2.
54. Perry JL, Nelson SE, Carroll ME. Impulsive choice as a predictor of acquisition of IV cocaine self- administration and reinstatement of cocaine-seeking behavior in male and female rats. Exp Clin Psychopharmacol (2008) 16:165-77. doi:10.1037/1064-1297.16.2.165.